CIBC World Market’s Dr. Reddy's Laboratories RDY Stock Holding History

CIBC World Market’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-63,000	Closed	-$924K	–	1343
2024 Q1	$924K	Hold	63,000	–	–	﹤0.01%	834
2023 Q4	$877K	Hold	63,000	–	–	﹤0.01%	796
2023 Q3	$843K	Hold	63,000	–	–	﹤0.01%	778
2023 Q2	$795K	Hold	63,000	–	–	﹤0.01%	822
2023 Q1	$717K	Hold	63,000	–	–	﹤0.01%	832
2022 Q4	$652K	Hold	63,000	–	–	﹤0.01%	867
2022 Q3	$659K	Hold	63,000	–	–	﹤0.01%	819
2022 Q2	$698K	Hold	63,000	–	–	﹤0.01%	801
2022 Q1	$702K	Hold	63,000	–	–	﹤0.01%	836
2021 Q4	$824K	Hold	63,000	–	–	﹤0.01%	833
2021 Q3	$821K	Buy	+63,000	New	+$839K	﹤0.01%	834
2020 Q4	–	Sell	-65,540	Closed	-$912K	–	1320
2020 Q3	$912K	Buy	+65,540	New	+$781K	﹤0.01%	673

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CIBC World Market's RDY Position: Q2 2024 in Review

CIBC World Market sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 63,000 shares — an estimated $924K sold.

CIBC World Market first reported a position in RDY in Q3 2020 and held it in 12 quarters. The position peaked at $924K in Q1 2024. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

CIBC World Market reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
CIBC World Market sold 63,000 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $924K.
CIBC World Market first reported a position in Dr. Reddy's Laboratories in Q3 2020 and held it in 12 quarters.
CIBC World Market's Dr. Reddy's Laboratories position peaked at $924K in Q1 2024.
222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on CIBC World Market's 13F filing for Q2 2024, filed 7 Aug 2024.